Ligand-directed therapy and molecular imaging based on in vivo phage display technology
Wadih Arap
Rutgers Cancer Institute of New Jersey, USA
: J Mol Biol Methods
Abstract
We have created in vivo phage show, a useful peptide and immune response screening set up in creature models and later in patients. Confinement of homing ligands empowers ensuing recognizable proof of tissue-particular receptors. Efficient usage of this procedure will prompt the development of an exhaustive guide of vascular markers in every organ, tissue, or infection, and may result in pharmacology.
Biography
Wadih Arap has worked as the Chief of Haematology/Oncology Division and as Deputy Director at the University of New Mexico Comprehensive Cancer Centre. Assuming the director position from Susan Godin, Pharm.D, who served in an interim capacity, Arap will also be taking on the role of chief in the Division of Haematology/Oncology in the Department of Medicine at Rutgers New Jersey Medical School. Rutgers Cancer Institute Director Steven K. Libutti, MC, FACS, spoke about what is expected when Arap joins the team. “Under his leadership, opportunities will be developed to reduce cancer incidence and improve patient outcomes through enhanced clinical services and research’’.
E-mail: wa116@rutgers.edu
